Tom Farrell is the founder of Artiva Biotherapeutics. Artiva Biotherapeutics has raised $198M in total funding. Latest round: Series B.
Tom Farrell is the Co-founder and former Chief Executive Officer of Artiva Biotherapeutics, a San Diego-based biotechnology company. He raised a $78 million Series A in June 2020 and a $120 million Series B in February 2021, and supported the company through a strategic partnership with Merck and an S-1 filing. Prior to Artiva, he was the founding CEO of two public cell therapy companies, including Cylene Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library